E. Akin et al., Expression of adhesion molecules in synovia of patients with treatment-resistant Lyme arthritis, INFEC IMMUN, 69(3), 2001, pp. 1774-1780
The expression of adhesion molecules in synovium in patients with Lyme arth
ritis is surely critical in the control of Borrelia burgdorferi infection b
ut may also have pathologic consequences. For example, molecular mimicry be
tween a dominant T-cell epitope of B, burgdorferi outer surface protein A a
nd an adhesion molecule, human lymphocyte function-associated antigen 1 (LF
A-1), has been implicated in the pathogenesis of treatment-resistant Lyme a
rthritis. Using immunohistochemical methods, we examined synovial samples f
or expression of adhesion molecules in 29 patients with treatment-resistant
Lyme arthritis and in 15 patients with rheumatoid arthritis or chronic inf
lammatory monoarthritis, In Lyme arthritis synovia, endothelial cells showe
d intense expression of P-selectin and vascular adhesion protein-1 (VAP-1),
Expression of LFA-1 was also intense on infiltrating cells, particularly i
n lymphoid aggregates, and intercellular adhesion molecule-1 (ICAM-1) was m
arkedly expressed on synovial lining and endothelial and infiltrating cells
, Moderate expression of vascular cell adhesion molecule-1 (VCAM-1) was see
n on synovial lining and endothelial cells, and mild expression of its liga
nd, very late antigen-4, was apparent in perivascular lymphoid infiltrates.
Except for lesser expression of VCAM-1 in Lyme synovia, the levels of expr
ession of these adhesion molecules were similar in the three patient groups
, We conclude that certain adhesion molecules, including ICAM-1 and LFA-1,
are expressed intensely in the synovia of patients with Lyme arthritis. Upr
egulation of LFA-1 on lymphocytes in this lesion may be critical in the pat
hogenesis of treatment-resistant Lyme arthritis.